ArticleCancer research2025

KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition.

Sigrid K Fey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.